Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.62327 | 26 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.54289 | 23 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.5502 | 24 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.56444 | 27 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.48351 | 23 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.6575 | 26 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.62681 | 25 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.53186 | 24 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.50641 | 23 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.53577 | 23 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.5298 | 23 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.5029 | 23 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.55502 | 24 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.55247 | 24 |